about
Predicted protein interactions of IFITMs which inhibit Zika virus infectionZika virus and pregnancy: An overviewMolecular and cellular insights into Zika virus-related neuropathiesZika virus protection by a single low-dose nucleoside-modified mRNA vaccinationZika Virus Infects Early- and Midgestation Human Maternal Decidual Tissues, Inducing Distinct Innate Tissue Responses in the Maternal-Fetal InterfaceThe Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and ImmunoprophylaxisZika Virus infection of rhesus macaques leads to viral persistence in multiple tissuesVaccines for Epidemic Infections and the Role of CEPICutting Edge: Innate Immune Augmenting Vesicular Stomatitis Virus Expressing Zika Virus Proteins Confers Protective ImmunityUltrastructural Characterization of Zika Virus Replication FactoriesMaternal-Fetal Transmission of Zika Virus: Routes and Signals for InfectionRecurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.Prospects for a Zika Virus Vaccine.Animal Models of Zika Virus Infection, Pathogenesis, and Immunity.DNA vaccination protects mice against Zika virus-induced damage to the testesEffective Suckling C57BL/6, Kunming, and BALB/c Mouse Models with Remarkable Neurological Manifestation for Zika Virus InfectionZika Virus Escapes NK Cell Detection by Upregulating Major Histocompatibility Complex Class I Molecules.Recent Perspectives on Genome, Transmission, Clinical Manifestation, Diagnosis, Therapeutic Strategies, Vaccine Developments, and Challenges of Zika Virus ResearchInnate, T and B Cell Responses in Acute Human Zika Patients.Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans.Construction and Identification of Recombinant HEK293T Cell Lines Expressing Non-structural Protein 1 of Zika Virus.Zika vaccine candidates progress through nonclinical development and enter clinical trials.Zika virus infection induces host inflammatory responses by facilitating NLRP3 inflammasome assembly and interleukin-1β secretion.Human T cell responses to Dengue and Zika virus infection compared to Dengue/Zika coinfection.Immune Response to Dengue and Zika.New advances in CNS immunity against viral infection.Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic.Specialty Grand Challenge In Pediatric Infectious Diseases.Antiviral effects of ferric ammonium citrate.Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice.Environmental and social determinants of population vulnerability to Zika virus emergence at the local scale.Selective constraint and adaptive potential of West Nile virus within and among naturally infected avian hosts and mosquito vectors.Zika: An emerging disease requiring prevention and awareness.E90 subunit vaccine protects mice from Zika virus infection and microcephalyA conceptual model for optimizing vaccine coverage to reduce vector-borne infections in the presence of antibody-dependent enhancement
P2860
Q26247786-DAEC5D42-2838-4F9C-B997-C7F7FEAF61CCQ28119241-7BE03859-C5C5-4607-8E71-9BACAD54C0A0Q28577785-04A3823F-CA8D-4737-9BD4-C3E4A75F8303Q28656365-3BD56E4C-3E39-4FDA-926E-24E6E935A0B1Q28733414-61B098B2-ACD8-4391-B119-2A304E2AABBCQ28804225-1E40B87A-A451-43B7-9361-5A97B1D6655EQ28954543-E0F876A0-E4CD-4F7C-95E5-95D4D7F31C38Q29224804-C03A305F-EE45-4E6B-8E3E-AFEE05F7D404Q29365197-888FBA50-C895-4ADB-B4F9-32ADC94541C8Q29365441-3AB920CD-CCFA-468F-B040-8EB62D37C1D5Q29451356-98275EFA-A8AE-4F5D-9EFB-9DCF4EC29274Q30145646-F37E327A-6AA2-469A-8BA9-502340C4C23EQ30235612-3A4129EF-497C-4588-A509-A535A8C753D5Q30238657-CE030394-7130-4115-A6E0-3D5D6D3EA5EBQ30855414-86ED36EE-56DD-4378-B3CC-98A80D03D303Q38158334-98310089-675E-45B5-9405-9E6854776E6CQ40037742-734A757E-E892-4119-AF30-435893656A51Q41673108-3564D4D7-F9FF-435B-AF06-A9B06CB30FB8Q41919129-06652781-A6FB-4238-A5B2-C566B087ECDEQ41924182-17985FD8-9539-4172-BFBC-E5994A26CCD0Q43046807-7C3F09EC-AA15-48BB-933F-ACADA810CF37Q47168453-46E1A163-8930-448F-8009-7A7F3A6D12F4Q47215672-C6297DAD-3CE9-4947-8FA3-FB1F4F666DDAQ47250288-961688F6-F03F-4616-A2AE-592FB318F6AAQ47551925-66DED2EF-38A2-45E3-96F7-3556225091CBQ47559442-66AF9B9A-6342-4588-8B2C-E9445414DDF2Q47570091-A9189C8A-7126-4DBA-B2FA-83595D048262Q50143779-4D381399-CE79-47A3-B973-1AFC953A29B8Q52605980-ABA75BAF-4686-4666-9B31-2CBA8C9DD52BQ54558196-90DBBC01-C07A-4DCD-9327-F6FAA944573BQ54558411-785940AF-3F03-4CC8-83A1-06A9C90A3278Q55340881-F8595B41-2F0E-4852-8DC9-982F661FAA35Q55496233-C6F5B9D2-C2E9-4648-B9C2-73AF8CDBA74AQ56341159-5FFE577C-91C5-4D64-BF01-AB2FB429BBD7Q58769644-BA42F4C7-02A7-4102-AB7D-3F30D00DADD1
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Zika Virus: Immunity and Vaccine Development.
@en
type
label
Zika Virus: Immunity and Vaccine Development.
@en
altLabel
Zika Virus: Immunity and Vaccine Development
@en
prefLabel
Zika Virus: Immunity and Vaccine Development.
@en
P2860
P1433
P1476
Zika Virus: Immunity and Vaccine Development.
@en
P2860
P304
P356
10.1016/J.CELL.2016.09.020
P407
P577
2016-09-28T00:00:00Z